ancitabine hydrochloride | CAS:10212-25-6

We serve ancitabine hydrochloride CAS:10212-25-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
ancitabine hydrochloride

Chemical Name:ancitabine hydrochloride
CAS.NO:10212-25-6
Synonyms:2,2'-Anhydro-(1-β-D-arabinofuranosyl)cytosine Hydrochloride
2,2'-Anhydro-1-β-D-arabinofuranosylcytosine hydrochloride
2,2'-O-Cyclocytidine Hydrochloride
Ancitabine Hydrochloride
(-)-Cyclocytidine hydrochloride
Molecular Formula:C9H12ClN3O4
Molecular Weight:261.66200
 
Physical and Chemical Properties:
Density:2.01
Melting point:269-270ºC
Boiling point:442ºC
Flash point:221.1ºC
 
Specification:
Appearance:White or off-white crystalline powder
Assay(HPLC):≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Anti-tumor pharmaceutical intermediates, also used in the manufacture of eye drops.



Contact us for information like 2,2′-Anhydro-(1-β-D-arabinofuranosyl)cytosine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(-)-Cyclocytidine hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,2′-O-Cyclocytidine Hydrochloride Use and application,2,2′-O-Cyclocytidine Hydrochloride technical grade,usp/ep/jp grade.


Related News: Further research on Oligomannate’s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement.Methylcyanocarbamate manufacturer Further research on Oligomannate’s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement.2-Fluoro-6-nitrobenzoic acid supplier Further research on Oligomannate’s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement.9-(8-Bromo-dibenzofuran-2-yl)-9H-carbazole vendor Further research on Oligomannate’s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement.ut others aren’t convinced — they think one of the country’s most influential state media outlets could be promoting pseudoscience and false hope.